img

Global Antiserum Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Antiserum Market Insights, Forecast to 2034

Antiserum, is a type of blood serum that contains specific antibodies against an antigen (foreign agent), such as an infective organism or poisonous substance. Antibodies in antiserum work by detecting and subsequently neutralizing antigens.
Antiserums are produced in animals, most commonly horses, sheep, oxen, and rabbits, and in humans, in response to infection, intoxication, or vaccination. Animal and human antiserums can be used in other individuals to confer immunity to a specific disease or to treat bites or stings of venomous animals.
Antiserum widely used in diagnostic virology laboratories. The most common use of antiserum in humans is as antitoxin or antivenom to treat envenomation.
Market Analysis and InsightsGlobal Antiserum Market
Global Antiserum market is expected to reach to US$ 1408.1 million in 2024, with a positive growth of %, compared with US$ 1288.9 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Antiserum industry is evaluated to reach US$ 2094.3 million in 2029. The CAGR will be 6.8% during 2024 to 2029.
Global 5 largest manufacturers of Antiserum are CSL, Merck, BTG, Pfizer and CNBG, which make up over 58%. Among them, CSL is the leader with about 16% market share.
Asia-Pacific is the largest market, with a share about 47%, followed by North America and Middle East and Africa, with the share about 24% and 12%. In terms of product type, Antitoxin Serum occupies the largest share of the total market, about 61%. And in terms of application, the largest application is Clinical, followed by Laboratory.
Report Covers
This report presents an overview of global Antiserum market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Antiserum market with multiple angles. Items like regional revenue from 2018 to 2029 and companies’ revenue and gross margin from 2018 to 2024 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Companies, Type, Application and Regions Listed in the Report



By Company


BD
Bio-Rad
Shanghai Serum Bio-Technology Co., Ltd.
China National Pharmaceutical Group
CSL
Merck
BTG
Pfizer
Haffkine Bio-Pharmaceutical
Vins Bioproducts
Bharat Serums and Vaccines
SSI Diagnostica
GD Animal Health
MicroPharm
Peptide Institute Inc.
Rare Disease Therapeutics
Segment by Type
Antitoxin Serum
Antibacterial Serum
Antiviral Serum
Others

Segment by Application


Clinical
Laboratory
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2029
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2029 globally
Chapter 5Product revenue analysis by application from 2018 to 2029 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2029 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product revenue analysis by type and application from 2018 to 2029 in Europe. Product revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product revenue analysis by type and application from 2018 to 2029 in China. Product revenue analysis of China from 2018 to 2029
Chapter 9Product revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Companies’ outline, covering company’s basic information, major business, Antiserum introduction, etc. Antiserum Revenue and Gross Margin of each company from 2018 to 2024
Chapter 12Mr Accuracy reports Conclusions of Antiserum
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Antiserum Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Antitoxin Serum
1.2.3 Antibacterial Serum
1.2.4 Antiviral Serum
1.2.5 Others
1.3 Market by Application
1.3.1 Global Antiserum Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Clinical
1.3.3 Laboratory
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Antiserum Market Perspective (2018-2029)
2.2 Global Antiserum Growth Trends by Region
2.2.1 Antiserum Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Antiserum Historic Market Size by Region (2018-2024)
2.2.3 Antiserum Forecasted Market Size by Region (2024-2029)
2.3 Antiserum Market Dynamics
2.3.1 Antiserum Industry Trends
2.3.2 Antiserum Market Drivers
2.3.3 Antiserum Market Challenges
2.3.4 Antiserum Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Antiserum by Players
3.1.1 Global Antiserum Revenue by Players (2018-2024)
3.1.2 Global Antiserum Revenue Market Share by Players (2018-2024)
3.2 Global Antiserum Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Antiserum, Ranking by Revenue, 2021 VS 2022 VS 2024
3.4 Global Antiserum Market Concentration Ratio
3.4.1 Global Antiserum Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Antiserum Revenue in 2022
3.5 Global Key Players of Antiserum Head office and Area Served
3.6 Global Key Players of Antiserum, Product and Application
3.7 Global Key Players of Antiserum, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Antiserum Breakdown Data by Type
4.1 Global Antiserum Historic Market Size by Type (2018-2024)
4.2 Global Antiserum Forecasted Market Size by Type (2024-2029)
5 Antiserum Breakdown Data by Application
5.1 Global Antiserum Historic Market Size by Application (2018-2024)
5.2 Global Antiserum Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Antiserum Market Size (2018-2029)
6.2 North America Antiserum Market Size by Type
6.2.1 North America Antiserum Market Size by Type (2018-2024)
6.2.2 North America Antiserum Market Size by Type (2024-2029)
6.2.3 North America Antiserum Market Share by Type (2018-2029)
6.3 North America Antiserum Market Size by Application
6.3.1 North America Antiserum Market Size by Application (2018-2024)
6.3.2 North America Antiserum Market Size by Application (2024-2029)
6.3.3 North America Antiserum Market Share by Application (2018-2029)
6.4 North America Antiserum Market Size by Country
6.4.1 North America Antiserum Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Antiserum Market Size by Country (2018-2024)
6.4.3 North America Antiserum Market Size by Country (2024-2029)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Antiserum Market Size (2018-2029)
7.2 Europe Antiserum Market Size by Type
7.2.1 Europe Antiserum Market Size by Type (2018-2024)
7.2.2 Europe Antiserum Market Size by Type (2024-2029)
7.2.3 Europe Antiserum Market Share by Type (2018-2029)
7.3 Europe Antiserum Market Size by Application
7.3.1 Europe Antiserum Market Size by Application (2018-2024)
7.3.2 Europe Antiserum Market Size by Application (2024-2029)
7.3.3 Europe Antiserum Market Share by Application (2018-2029)
7.4 Europe Antiserum Market Size by Country
7.4.1 Europe Antiserum Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Antiserum Market Size by Country (2018-2024)
7.4.3 Europe Antiserum Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Antiserum Market Size (2018-2029)
8.2 China Antiserum Market Size by Type
8.2.1 China Antiserum Market Size by Type (2018-2024)
8.2.2 China Antiserum Market Size by Type (2024-2029)
8.2.3 China Antiserum Market Share by Type (2018-2029)
8.3 China Antiserum Market Size by Application
8.3.1 China Antiserum Market Size by Application (2018-2024)
8.3.2 China Antiserum Market Size by Application (2024-2029)
8.3.3 China Antiserum Market Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Antiserum Market Size (2018-2029)
9.2 Asia Antiserum Market Size by Type
9.2.1 Asia Antiserum Market Size by Type (2018-2024)
9.2.2 Asia Antiserum Market Size by Type (2024-2029)
9.2.3 Asia Antiserum Market Share by Type (2018-2029)
9.3 Asia Antiserum Market Size by Application
9.3.1 Asia Antiserum Market Size by Application (2018-2024)
9.3.2 Asia Antiserum Market Size by Application (2024-2029)
9.3.3 Asia Antiserum Market Share by Application (2018-2029)
9.4 Asia Antiserum Market Size by Region
9.4.1 Asia Antiserum Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Antiserum Market Size by Region (2018-2024)
9.4.3 Asia Antiserum Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Antiserum Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Antiserum Market Size by Type
10.2.1 Middle East, Africa, and Latin America Antiserum Market Size by Type (2018-2024)
10.2.2 Middle East, Africa, and Latin America Antiserum Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Antiserum Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Antiserum Market Size by Application
10.3.1 Middle East, Africa, and Latin America Antiserum Market Size by Application (2018-2024)
10.3.2 Middle East, Africa, and Latin America Antiserum Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Antiserum Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Antiserum Market Size by Country
10.4.1 Middle East, Africa, and Latin America Antiserum Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Antiserum Market Size by Country (2018-2024)
10.4.3 Middle East, Africa, and Latin America Antiserum Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 BD
11.1.1 BD Company Details
11.1.2 BD Business Overview
11.1.3 BD Antiserum Introduction
11.1.4 BD Revenue in Antiserum Business (2018-2024)
11.1.5 BD Recent Developments
11.2 Bio-Rad
11.2.1 Bio-Rad Company Details
11.2.2 Bio-Rad Business Overview
11.2.3 Bio-Rad Antiserum Introduction
11.2.4 Bio-Rad Revenue in Antiserum Business (2018-2024)
11.2.5 Bio-Rad Recent Developments
11.3 Shanghai Serum Bio-Technology Co., Ltd.
11.3.1 Shanghai Serum Bio-Technology Co., Ltd. Company Details
11.3.2 Shanghai Serum Bio-Technology Co., Ltd. Business Overview
11.3.3 Shanghai Serum Bio-Technology Co., Ltd. Antiserum Introduction
11.3.4 Shanghai Serum Bio-Technology Co., Ltd. Revenue in Antiserum Business (2018-2024)
11.3.5 Shanghai Serum Bio-Technology Co., Ltd. Recent Developments
11.4 China National Pharmaceutical Group
11.4.1 China National Pharmaceutical Group Company Details
11.4.2 China National Pharmaceutical Group Business Overview
11.4.3 China National Pharmaceutical Group Antiserum Introduction
11.4.4 China National Pharmaceutical Group Revenue in Antiserum Business (2018-2024)
11.4.5 China National Pharmaceutical Group Recent Developments
11.5 CSL
11.5.1 CSL Company Details
11.5.2 CSL Business Overview
11.5.3 CSL Antiserum Introduction
11.5.4 CSL Revenue in Antiserum Business (2018-2024)
11.5.5 CSL Recent Developments
11.6 Merck
11.6.1 Merck Company Details
11.6.2 Merck Business Overview
11.6.3 Merck Antiserum Introduction
11.6.4 Merck Revenue in Antiserum Business (2018-2024)
11.6.5 Merck Recent Developments
11.7 BTG
11.7.1 BTG Company Details
11.7.2 BTG Business Overview
11.7.3 BTG Antiserum Introduction
11.7.4 BTG Revenue in Antiserum Business (2018-2024)
11.7.5 BTG Recent Developments
11.8 Pfizer
11.8.1 Pfizer Company Details
11.8.2 Pfizer Business Overview
11.8.3 Pfizer Antiserum Introduction
11.8.4 Pfizer Revenue in Antiserum Business (2018-2024)
11.8.5 Pfizer Recent Developments
11.9 Haffkine Bio-Pharmaceutical
11.9.1 Haffkine Bio-Pharmaceutical Company Details
11.9.2 Haffkine Bio-Pharmaceutical Business Overview
11.9.3 Haffkine Bio-Pharmaceutical Antiserum Introduction
11.9.4 Haffkine Bio-Pharmaceutical Revenue in Antiserum Business (2018-2024)
11.9.5 Haffkine Bio-Pharmaceutical Recent Developments
11.10 Vins Bioproducts
11.10.1 Vins Bioproducts Company Details
11.10.2 Vins Bioproducts Business Overview
11.10.3 Vins Bioproducts Antiserum Introduction
11.10.4 Vins Bioproducts Revenue in Antiserum Business (2018-2024)
11.10.5 Vins Bioproducts Recent Developments
11.11 Bharat Serums and Vaccines
11.11.1 Bharat Serums and Vaccines Company Details
11.11.2 Bharat Serums and Vaccines Business Overview
11.11.3 Bharat Serums and Vaccines Antiserum Introduction
11.11.4 Bharat Serums and Vaccines Revenue in Antiserum Business (2018-2024)
11.11.5 Bharat Serums and Vaccines Recent Developments
11.12 SSI Diagnostica
11.12.1 SSI Diagnostica Company Details
11.12.2 SSI Diagnostica Business Overview
11.12.3 SSI Diagnostica Antiserum Introduction
11.12.4 SSI Diagnostica Revenue in Antiserum Business (2018-2024)
11.12.5 SSI Diagnostica Recent Developments
11.13 GD Animal Health
11.13.1 GD Animal Health Company Details
11.13.2 GD Animal Health Business Overview
11.13.3 GD Animal Health Antiserum Introduction
11.13.4 GD Animal Health Revenue in Antiserum Business (2018-2024)
11.13.5 GD Animal Health Recent Developments
11.14 MicroPharm
11.14.1 MicroPharm Company Details
11.14.2 MicroPharm Business Overview
11.14.3 MicroPharm Antiserum Introduction
11.14.4 MicroPharm Revenue in Antiserum Business (2018-2024)
11.14.5 MicroPharm Recent Developments
11.15 Peptide Institute Inc.
11.15.1 Peptide Institute Inc. Company Details
11.15.2 Peptide Institute Inc. Business Overview
11.15.3 Peptide Institute Inc. Antiserum Introduction
11.15.4 Peptide Institute Inc. Revenue in Antiserum Business (2018-2024)
11.15.5 Peptide Institute Inc. Recent Developments
11.16 Rare Disease Therapeutics
11.16.1 Rare Disease Therapeutics Company Details
11.16.2 Rare Disease Therapeutics Business Overview
11.16.3 Rare Disease Therapeutics Antiserum Introduction
11.16.4 Rare Disease Therapeutics Revenue in Antiserum Business (2018-2024)
11.16.5 Rare Disease Therapeutics Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Antiserum Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of Antitoxin Serum
Table 3. Key Players of Antibacterial Serum
Table 4. Key Players of Antiviral Serum
Table 5. Key Players of Others
Table 6. Global Antiserum Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 7. Global Antiserum Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 8. Global Antiserum Market Size by Region (2018-2024) & (US$ Million)
Table 9. Global Antiserum Market Share by Region (2018-2024)
Table 10. Global Antiserum Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 11. Global Antiserum Market Share by Region (2024-2029)
Table 12. Antiserum Market Trends
Table 13. Antiserum Market Drivers
Table 14. Antiserum Market Challenges
Table 15. Antiserum Market Restraints
Table 16. Global Antiserum Revenue by Players (2018-2024) & (US$ Million)
Table 17. Global Antiserum Revenue Share by Players (2018-2024)
Table 18. Global Top Antiserum by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antiserum as of 2022)
Table 19. Global Antiserum Industry Ranking 2021 VS 2022 VS 2024
Table 20. Global 5 Largest Players Market Share by Antiserum Revenue (CR5 and HHI) & (2018-2024)
Table 21. Global Key Players of Antiserum, Headquarters and Area Served
Table 22. Global Key Players of Antiserum, Product and Application
Table 23. Global Key Players of Antiserum, Product and Application
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Antiserum Market Size by Type (2018-2024) & (US$ Million)
Table 26. Global Antiserum Revenue Market Share by Type (2018-2024)
Table 27. Global Antiserum Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 28. Global Antiserum Revenue Market Share by Type (2024-2029)
Table 29. Global Antiserum Market Size by Application (2018-2024) & (US$ Million)
Table 30. Global Antiserum Revenue Share by Application (2018-2024)
Table 31. Global Antiserum Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 32. Global Antiserum Revenue Share by Application (2024-2029)
Table 33. North America Antiserum Market Size by Type (2018-2024) & (US$ Million)
Table 34. North America Antiserum Market Size by Type (2024-2029) & (US$ Million)
Table 35. North America Antiserum Market Size by Application (2018-2024) & (US$ Million)
Table 36. North America Antiserum Market Size by Application (2024-2029) & (US$ Million)
Table 37. North America Antiserum Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 38. North America Antiserum Market Size by Country (2018-2024) & (US$ Million)
Table 39. North America Antiserum Market Size by Country (2024-2029) & (US$ Million)
Table 40. Europe Antiserum Market Size by Type (2018-2024) & (US$ Million)
Table 41. Europe Antiserum Market Size by Type (2024-2029) & (US$ Million)
Table 42. Europe Antiserum Market Size by Application (2018-2024) & (US$ Million)
Table 43. Europe Antiserum Market Size by Application (2024-2029) & (US$ Million)
Table 44. Europe Antiserum Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 45. Europe Antiserum Market Size by Country (2018-2024) & (US$ Million)
Table 46. Europe Antiserum Market Size by Country (2024-2029) & (US$ Million)
Table 47. China Antiserum Market Size by Type (2018-2024) & (US$ Million)
Table 48. China Antiserum Market Size by Type (2024-2029) & (US$ Million)
Table 49. China Antiserum Market Size by Application (2018-2024) & (US$ Million)
Table 50. China Antiserum Market Size by Application (2024-2029) & (US$ Million)
Table 51. Asia Antiserum Market Size by Type (2018-2024) & (US$ Million)
Table 52. Asia Antiserum Market Size by Type (2024-2029) & (US$ Million)
Table 53. Asia Antiserum Market Size by Application (2018-2024) & (US$ Million)
Table 54. Asia Antiserum Market Size by Application (2024-2029) & (US$ Million)
Table 55. Asia Antiserum Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 56. Asia Antiserum Market Size by Region (2018-2024) & (US$ Million)
Table 57. Asia Antiserum Market Size by Region (2024-2029) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Antiserum Market Size by Type (2018-2024) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Antiserum Market Size by Type (2024-2029) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Antiserum Market Size by Application (2018-2024) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Antiserum Market Size by Application (2024-2029) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Antiserum Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 63. Middle East, Africa, and Latin America Antiserum Market Size by Country (2018-2024) & (US$ Million)
Table 64. Middle East, Africa, and Latin America Antiserum Market Size by Country (2024-2029) & (US$ Million)
Table 65. BD Company Details
Table 66. BD Business Overview
Table 67. BD Antiserum Product
Table 68. BD Revenue in Antiserum Business (2018-2024) & (US$ Million)
Table 69. BD Recent Developments
Table 70. Bio-Rad Company Details
Table 71. Bio-Rad Business Overview
Table 72. Bio-Rad Antiserum Product
Table 73. Bio-Rad Revenue in Antiserum Business (2018-2024) & (US$ Million)
Table 74. Bio-Rad Recent Developments
Table 75. Shanghai Serum Bio-Technology Co., Ltd. Company Details
Table 76. Shanghai Serum Bio-Technology Co., Ltd. Business Overview
Table 77. Shanghai Serum Bio-Technology Co., Ltd. Antiserum Product
Table 78. Shanghai Serum Bio-Technology Co., Ltd. Revenue in Antiserum Business (2018-2024) & (US$ Million)
Table 79. Shanghai Serum Bio-Technology Co., Ltd. Recent Developments
Table 80. China National Pharmaceutical Group Company Details
Table 81. China National Pharmaceutical Group Business Overview
Table 82. China National Pharmaceutical Group Antiserum Product
Table 83. China National Pharmaceutical Group Revenue in Antiserum Business (2018-2024) & (US$ Million)
Table 84. China National Pharmaceutical Group Recent Developments
Table 85. CSL Company Details
Table 86. CSL Business Overview
Table 87. CSL Antiserum Product
Table 88. CSL Revenue in Antiserum Business (2018-2024) & (US$ Million)
Table 89. CSL Recent Developments
Table 90. Merck Company Details
Table 91. Merck Business Overview
Table 92. Merck Antiserum Product
Table 93. Merck Revenue in Antiserum Business (2018-2024) & (US$ Million)
Table 94. Merck Recent Developments
Table 95. BTG Company Details
Table 96. BTG Business Overview
Table 97. BTG Antiserum Product
Table 98. BTG Revenue in Antiserum Business (2018-2024) & (US$ Million)
Table 99. BTG Recent Developments
Table 100. Pfizer Company Details
Table 101. Pfizer Business Overview
Table 102. Pfizer Antiserum Product
Table 103. Pfizer Revenue in Antiserum Business (2018-2024) & (US$ Million)
Table 104. Pfizer Recent Developments
Table 105. Haffkine Bio-Pharmaceutical Company Details
Table 106. Haffkine Bio-Pharmaceutical Business Overview
Table 107. Haffkine Bio-Pharmaceutical Antiserum Product
Table 108. Haffkine Bio-Pharmaceutical Revenue in Antiserum Business (2018-2024) & (US$ Million)
Table 109. Haffkine Bio-Pharmaceutical Recent Developments
Table 110. Vins Bioproducts Company Details
Table 111. Vins Bioproducts Business Overview
Table 112. Vins Bioproducts Antiserum Product
Table 113. Vins Bioproducts Revenue in Antiserum Business (2018-2024) & (US$ Million)
Table 114. Vins Bioproducts Recent Developments
Table 115. Bharat Serums and Vaccines Company Details
Table 116. Bharat Serums and Vaccines Business Overview
Table 117. Bharat Serums and Vaccines Antiserum Product
Table 118. Bharat Serums and Vaccines Revenue in Antiserum Business (2018-2024) & (US$ Million)
Table 119. Bharat Serums and Vaccines Recent Developments
Table 120. SSI Diagnostica Company Details
Table 121. SSI Diagnostica Business Overview
Table 122. SSI Diagnostica Antiserum Product
Table 123. SSI Diagnostica Revenue in Antiserum Business (2018-2024) & (US$ Million)
Table 124. SSI Diagnostica Recent Developments
Table 125. GD Animal Health Company Details
Table 126. GD Animal Health Business Overview
Table 127. GD Animal Health Antiserum Product
Table 128. GD Animal Health Revenue in Antiserum Business (2018-2024) & (US$ Million)
Table 129. GD Animal Health Recent Developments
Table 130. MicroPharm Company Details
Table 131. MicroPharm Business Overview
Table 132. MicroPharm Antiserum Product
Table 133. MicroPharm Revenue in Antiserum Business (2018-2024) & (US$ Million)
Table 134. MicroPharm Recent Developments
Table 135. Peptide Institute Inc. Company Details
Table 136. Peptide Institute Inc. Business Overview
Table 137. Peptide Institute Inc. Antiserum Product
Table 138. Peptide Institute Inc. Revenue in Antiserum Business (2018-2024) & (US$ Million)
Table 139. Peptide Institute Inc. Recent Developments
Table 140. Rare Disease Therapeutics Company Details
Table 141. Rare Disease Therapeutics Business Overview
Table 142. Rare Disease Therapeutics Antiserum Product
Table 143. Rare Disease Therapeutics Revenue in Antiserum Business (2018-2024) & (US$ Million)
Table 144. Rare Disease Therapeutics Recent Developments
Table 145. Research Programs/Design for This Report
Table 146. Key Data Information from Secondary Sources
Table 147. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Antiserum Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global Antiserum Market Share by Type: 2022 VS 2029
Figure 3. Antitoxin Serum Features
Figure 4. Antibacterial Serum Features
Figure 5. Antiviral Serum Features
Figure 6. Others Features
Figure 7. Global Antiserum Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 8. Global Antiserum Market Share by Application: 2022 VS 2029
Figure 9. Clinical Case Studies
Figure 10. Laboratory Case Studies
Figure 11. Antiserum Report Years Considered
Figure 12. Global Antiserum Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 13. Global Antiserum Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global Antiserum Market Share by Region: 2022 VS 2029
Figure 15. Global Antiserum Market Share by Players in 2022
Figure 16. Global Top Antiserum Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antiserum as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Antiserum Revenue in 2022
Figure 18. North America Antiserum Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 19. North America Antiserum Market Share by Type (2018-2029)
Figure 20. North America Antiserum Market Share by Application (2018-2029)
Figure 21. North America Antiserum Market Share by Country (2018-2029)
Figure 22. United States Antiserum Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Canada Antiserum Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Europe Antiserum Market Size YoY (2018-2029) & (US$ Million)
Figure 25. Europe Antiserum Market Share by Type (2018-2029)
Figure 26. Europe Antiserum Market Share by Application (2018-2029)
Figure 27. Europe Antiserum Market Share by Country (2018-2029)
Figure 28. Germany Antiserum Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. France Antiserum Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. U.K. Antiserum Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Italy Antiserum Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Russia Antiserum Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Nordic Countries Antiserum Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. China Antiserum Market Size YoY (2018-2029) & (US$ Million)
Figure 35. China Antiserum Market Share by Type (2018-2029)
Figure 36. China Antiserum Market Share by Application (2018-2029)
Figure 37. Asia Antiserum Market Size YoY (2018-2029) & (US$ Million)
Figure 38. Asia Antiserum Market Share by Type (2018-2029)
Figure 39. Asia Antiserum Market Share by Application (2018-2029)
Figure 40. Asia Antiserum Market Share by Region (2018-2029)
Figure 41. Japan Antiserum Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. South Korea Antiserum Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. China Taiwan Antiserum Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Southeast Asia Antiserum Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. India Antiserum Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Australia Antiserum Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Middle East, Africa, and Latin America Antiserum Market Size YoY (2018-2029) & (US$ Million)
Figure 48. Middle East, Africa, and Latin America Antiserum Market Share by Type (2018-2029)
Figure 49. Middle East, Africa, and Latin America Antiserum Market Share by Application (2018-2029)
Figure 50. Middle East, Africa, and Latin America Antiserum Market Share by Country (2018-2029)
Figure 51. Brazil Antiserum Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 52. Mexico Antiserum Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 53. Turkey Antiserum Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 54. Saudi Arabia Antiserum Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 55. Israel Antiserum Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 56. GCC Countries Antiserum Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 57. BD Revenue Growth Rate in Antiserum Business (2018-2024)
Figure 58. Bio-Rad Revenue Growth Rate in Antiserum Business (2018-2024)
Figure 59. Shanghai Serum Bio-Technology Co., Ltd. Revenue Growth Rate in Antiserum Business (2018-2024)
Figure 60. China National Pharmaceutical Group Revenue Growth Rate in Antiserum Business (2018-2024)
Figure 61. CSL Revenue Growth Rate in Antiserum Business (2018-2024)
Figure 62. Merck Revenue Growth Rate in Antiserum Business (2018-2024)
Figure 63. BTG Revenue Growth Rate in Antiserum Business (2018-2024)
Figure 64. Pfizer Revenue Growth Rate in Antiserum Business (2018-2024)
Figure 65. Haffkine Bio-Pharmaceutical Revenue Growth Rate in Antiserum Business (2018-2024)
Figure 66. Vins Bioproducts Revenue Growth Rate in Antiserum Business (2018-2024)
Figure 67. Bharat Serums and Vaccines Revenue Growth Rate in Antiserum Business (2018-2024)
Figure 68. SSI Diagnostica Revenue Growth Rate in Antiserum Business (2018-2024)
Figure 69. GD Animal Health Revenue Growth Rate in Antiserum Business (2018-2024)
Figure 70. MicroPharm Revenue Growth Rate in Antiserum Business (2018-2024)
Figure 71. Peptide Institute Inc. Revenue Growth Rate in Antiserum Business (2018-2024)
Figure 72. Rare Disease Therapeutics Revenue Growth Rate in Antiserum Business (2018-2024)
Figure 73. Bottom-up and Top-down Approaches for This Report
Figure 74. Data Triangulation
Figure 75. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries